Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 8, Issue 10, 2010, Pages

[No Author Info available]

Author keywords

blood lipids; brain function; DHA; Docosahexaenoic acid; health claims; oxidative damage; spermatozoa motility; vision; weight management

Indexed keywords

EID: 85078384609     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2010.1734     Document Type: Article

References (7)

1. Carlson SE, Neuringer M and Reisbick S, 1997. Assessment of infant visual and cognitive function in relation to long chain polyunsaturated fatty acids. Editions Roche, Basel, Switzerland.
2. IoM (Institute of Medicine), 2005. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. The National Academies Press, Washington DC, 1331 pp.
3. Kelley DS, Siegel D, Vemuri M and Mackey BE, 2007. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. American Journal of Clinical Nutrition, 86, 324–333.
4. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD and Beilin LJ, 2000. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. American Journal of Clinical Nutrition, 71, 1085–1094.
5. Mori TA and Woodman RJ, 2006. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Current Opinion in Clinical Nutrition and Metabolic Care, 9, 95–104.
6. Von Schacky C, 2006. A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels. Vascular Health and Risk Management, 2, 251–262.
7. Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Best JD and Beilin LJ, 2003. Docosahexaenoic acid but not eicosapentaenoic acid increases LDL particle size in treated hypertensive type 2 diabetic patients. Diabetes Care, 26, 253.